secwatch / observer
8-K filed November 9, 2022, 6:59 PM ET ticker CYN CIK 0001874097
earnings confidence high sentiment negative materiality 0.60

Cyngn Q3 2022 net loss widens to $5.3M; cash $27.7M; announces new contracts

Cyngn Inc.

2022-Q3 EPS reported -$0.45

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cyngn Inc. reported the third fiscal quarter ended September 30, 2022 results: net income Net loss was $5.3 million for the quarter ended September 30, 2022, EPS Net loss per share on a basic and diluted basis was $0.16.

Period
the third fiscal quarter ended September 30, 2022
Net income
Net loss was $5.3 million for the quarter ended September 30, 2022
EPS
Net loss per share on a basic and diluted basis was $0.16
Result
reported results
Exact text from the filing
Cyngn Inc. issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2022.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cyngn Inc. reported the nine months ended September 30, 2022 results: net income Net loss was $13.7 million for the nine months ended September 30, 2022, EPS Net loss per share on a basic and diluted basis was $0.45.

Period
the nine months ended September 30, 2022
Net income
Net loss was $13.7 million for the nine months ended September 30, 2022
EPS
Net loss per share on a basic and diluted basis was $0.45
Result
reported results
Exact text from the filing
Cyngn Inc. issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2022.
View on SEC.gov

50 earnings releases filed in the last 30 days. Browse all earnings releases →

Cyngn Inc. filing history →

Source: SEC EDGAR
accession 0001213900-22-070660
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.